Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health · Information Technology
Size
11-50 employees
Stage
Other
founded in
2021
Unravel Biosciences is a therapeutics company that transforms drug development by clinically derisking new targets using existing drugs. Their AI-powered platform leverages patient data to identify therapeutic mechanisms and specify molecules for treatment, significantly accelerating the discovery process. With a focus on complex disorders, they have achieved notable traction, including FDA Orphan Drug Designation for a new molecule targeting Rett syndrome and a higher hit rate of in silico predictions compared to traditional methods. Their innovative approach allows for rapid clinical impact, making them a strong player in the biopharmaceutical landscape.
Something looks off?